News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
93,435 Results
Type
Article (2409)
Company Profile (29)
Press Release (90996)
Section
Business (42563)
Career Advice (94)
Deals (6597)
Drug Delivery (5)
Drug Development (9712)
Employer Resources (4)
FDA (1567)
Job Trends (2272)
News (57450)
Policy (2743)
Tag
Academia (184)
Accelerated approval (3)
Allergies (14)
Alliances (2703)
ALS (44)
Alzheimer's disease (253)
Antibody-drug conjugate (ADC) (49)
Approvals (1667)
Artificial intelligence (27)
Autoimmune disease (14)
Automation (2)
Bankruptcy (17)
Best Places to Work (2127)
Biosimilars (19)
Biotechnology (16)
Bladder cancer (30)
Brain cancer (4)
Breast cancer (110)
Cancer (708)
Cardiovascular disease (38)
Career advice (89)
Career pathing (4)
CAR-T (21)
CDC (1)
Cell therapy (62)
Cervical cancer (11)
Clinical research (8954)
Collaboration (92)
Compensation (90)
Complete response letters (2)
COVID-19 (226)
CRISPR (7)
C-suite (32)
Cystic fibrosis (9)
Data (1055)
Depression (15)
Diabetes (52)
Diagnostics (1029)
Digital health (6)
Drug discovery (13)
Drug pricing (6)
Duchenne muscular dystrophy (23)
Earnings (40369)
Editorial (3)
Employer branding (1)
Employer resources (5)
Events (13772)
Executive appointments (44)
FDA (2151)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (10)
Funding (92)
Gene editing (13)
Generative AI (2)
Gene therapy (42)
GLP-1 (94)
Government (330)
Guidances (286)
Healthcare (2688)
HIV (7)
Huntington's disease (2)
IgA nephropathy (12)
Immunology and inflammation (21)
Immuno-oncology (4)
Indications (11)
Infectious disease (248)
Inflammatory bowel disease (19)
Influenza (12)
Intellectual property (15)
Interviews (9)
IPO (5225)
IRA (2)
Job creations (269)
Job search strategy (82)
Kidney cancer (3)
Labor market (11)
Layoffs (55)
Leadership (1)
Legal (378)
Liver cancer (8)
Longevity (1)
Lung cancer (130)
Lymphoma (77)
Machine learning (3)
Management (1)
Manufacturing (56)
MASH (33)
Medical device (2355)
Medtech (2361)
Mergers & acquisitions (1525)
Metabolic disorders (156)
Multiple sclerosis (17)
NASH (3)
Neurodegenerative disease (39)
Neuropsychiatric disorders (15)
Neuroscience (421)
NextGen: Class of 2025 (602)
Non-profit (347)
Now hiring (1)
Obesity (63)
Opinion (18)
Ovarian cancer (18)
Pain (25)
Pancreatic cancer (23)
Parkinson's disease (25)
Partnered (1)
Patents (31)
Patient recruitment (25)
Peanut (5)
People (2600)
Pharmaceutical (9)
Pharmacy benefit managers (3)
Phase I (2280)
Phase II (3788)
Phase III (3658)
Pipeline (1476)
Policy (7)
Postmarket research (312)
Preclinical (657)
Prostate cancer (28)
Radiopharmaceuticals (29)
Rare diseases (80)
Real estate (341)
Recruiting (3)
Regulatory (2465)
Reports (12)
Research institute (158)
Resumes & cover letters (6)
Rett syndrome (4)
RNA editing (1)
RSV (6)
Schizophrenia (30)
Series A (8)
Series B (4)
Service/supplier (2)
Sickle cell disease (10)
Special edition (3)
Spinal muscular atrophy (8)
Sponsored (1)
Startups (168)
Stomach cancer (4)
Supply chain (7)
Tariffs (6)
The Weekly (1)
Vaccines (100)
Venture capital (10)
Weight loss (37)
Women's health (12)
Worklife (3)
Date
Today (2)
Last 7 days (18)
Last 30 days (271)
Last 365 days (6035)
2025 (6030)
2024 (6969)
2023 (8226)
2022 (8971)
2021 (9096)
2020 (8564)
2019 (5866)
2018 (4328)
2017 (4428)
2016 (3257)
2015 (4123)
2014 (2946)
2013 (1852)
2012 (2326)
2011 (2542)
2010 (2236)
Location
Africa (76)
Alabama (5)
Arizona (36)
Arkansas (1)
Asia (4021)
Australia (892)
California (2145)
Canada (488)
China (98)
Colorado (115)
Connecticut (89)
Delaware (83)
Europe (11262)
Florida (298)
Georgia (92)
Idaho (4)
Illinois (123)
India (8)
Indiana (133)
Iowa (2)
Japan (75)
Kansas (24)
Kentucky (7)
Louisiana (7)
Maine (15)
Maryland (217)
Massachusetts (1557)
Michigan (61)
Minnesota (111)
Mississippi (1)
Missouri (19)
Montana (5)
Nebraska (3)
Nevada (11)
New Hampshire (17)
New Jersey (724)
New Mexico (1)
New York (540)
North Carolina (273)
Northern California (1083)
Ohio (39)
Oregon (2)
Pennsylvania (382)
Rhode Island (3)
South America (106)
South Carolina (2)
Southern California (885)
Tennessee (14)
Texas (231)
United States (7540)
Utah (91)
Virginia (22)
Washington D.C. (5)
Washington State (177)
Wisconsin (19)
93,435 Results for "43".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cell-Based Assays Market Expands Toward USD 43.9 Billion by 2035
December 5, 2025
·
1 min read
Press Releases
Prothena Announces Poster Presentation on its TDP-43 CYTOPE® Program at Neuroscience 2025
November 20, 2025
·
4 min read
Press Releases
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
December 19, 2025
·
5 min read
Press Releases
Cancer Biomarkers Market Size Worth USD 43.05 Bn by 2034 Powered by Expanding Use of Liquid Biopsy Technologies
December 9, 2025
·
1 min read
Press Releases
BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes
November 24, 2025
·
4 min read
Press Releases
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
November 11, 2025
·
7 min read
Press Releases
Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S
November 14, 2025
·
4 min read
Press Releases
VectorY Therapeutics Receives FDA Clearance of IND to Proceed with the PIONEER-ALS Phase 1/2 Trial of VTx-002, a First-in-Class Vectorized Antibody Targeting TDP-43 Pathology in ALS
December 3, 2025
·
1 min read
Press Releases
VectorY Therapeutics Receives FDA Clearance of IND to Proceed with the PIONEER-ALS Phase 1/2 Trial of VTx-002, a First-in-Class Vectorized Antibody Targeting TDP-43 Pathology in ALS
December 3, 2025
·
4 min read
Press Releases
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine
October 27, 2025
·
6 min read
1 of 9,344
Next
